Clinical trial
The Effectiveness of Oral Lactobacillus Rhamnosus TCELL-1 Upon Colorectal Cancer
NCT05570942 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effectiveness of Oral Lactobacillus Rhamnosus TCELL-1 Upon Colorectal Cancer
- Lead sponsor
- National Taiwan University Hospital
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- December 7, 2021
- Completion date
- December 31, 2022
- Enrollment
- 56 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
staged iii colorectal cancer receiving adjuvant chemotherapy